Elizabeth A Phelan

Dr. Elizabeth A Phelan

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2012 in JAMA
Verified
Journal Article
Open access
PDF file
EPElizabeth A Phelan
Elizabeth A Phelan
SBSoo Borson
Soo Borson
LGLouis Grothaus
Louis Grothaus
SBSteven Balch
Steven Balch
ELEric B Larson
Eric B Larson
Claims-based, retrospective studies have long reported that dementia is associated with increased hospitalizations,1-9 but empirical data to elucidate this finding are few. Suboptimal management in the outpatient setting may be a contributing factor, as suggested by lower prescription drug costs and fewer office visits after diagnosis.4 Accomplishing adequate chronic disease management is more difficult in persons with dementia, which may lead to hospitalization for acute exacerbation of comorbid conditions.4,5 Nonelective hospitalization of older people, particularly those with dementia, is not a trivial event. Among older persons without dementia, hospitalization for serious illness is associated with subsequent cognitive decline,10 and frail elders, including those with dementia, are at increased risk of delirium, functional decline, and iatrogenic complications during an inpatient stay.11-13 Identifying conditions that precipitate hospitalization of elderly individuals with dementia could focus clinical priorities on secondary and tertiary prevention in the outpatient setting and improve health care for this vulnerable and increasing population. We used a unique longitudinal data set to determine whether dementia onset is associated with higher rates of or different reasons for hospitalization, particularly for ambulatory care–sensitive conditions (ACSCs), for which proactive outpatient care might prevent the need for a hospital stay.

1 March 2015 in Medical Clinics of North America
Verified
Journal Article
Closed access
EPElizabeth A Phelan
Elizabeth A Phelan
JMJane E. Mahoney
Jane E. Mahoney
JVJan C. Voit
Jan C. Voit
JSJudy A. Stevens
Judy A. Stevens

1 January 2011 in Journal of Aging Research
Verified
Journal Article
Open access
PDF file
RCRebecca Calhoun
Rebecca Calhoun
HMHendrika Meischke
Hendrika Meischke
KHKristen Hammerback
Kristen Hammerback
ABAlex Bohl
Alex Bohl
PPPamela Poe
Pamela Poe
EPElizabeth A Phelan
Elizabeth A Phelan
Objective. To investigate motivational factors and barriers to participating in fall risk assessment and management programs among diverse, low-income, community-dwelling older adults who had experienced a fall.Methods. Face-to-face interviews with 20 elderly who had accepted and 19 who had not accepted an invitation to an assessment by one of two fall prevention programs. Interviews covered healthy aging, core values, attributions/consequences of the fall, and barriers/benefits of fall prevention strategies and programs.Results. Joiners and nonjoiners of fall prevention programs were similar in their experience of loss associated with aging, core values they expressed, and emotional response to falling. One difference was that those who participated endorsed that they “needed” the program, while those who did not participate expressed a lack of need.Conclusions. Interventions targeted at a high-risk group need to address individual beliefs as well as structural and social factors (transportation issues, social networks) to enhance participation.

1 July 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
EPElizabeth A Phelan
Elizabeth A Phelan
BWBrian D. Williamson
Brian D. Williamson
BBBenjamin H. Balderson
Benjamin H. Balderson
ACAndrea J. Cook
Andrea J. Cook
APAnnalisa V. Piccorelli
Annalisa V. Piccorelli
SGShelly L. Gray
Shelly L. Gray
Importance: High-risk medications that contribute to adverse health outcomes are frequently prescribed to older adults. Deprescribing interventions reduce their use, but studies are often not designed to examine effects on patient-relevant health outcomes.Objective: To test the effect of a health system–embedded deprescribing intervention targeting older adults and their primary care clinicians for reducing the use of central nervous system–active drugs and preventing medically treated falls.Design, Setting, and Participants: In this cluster randomized, parallel-group, clinical trial, 18 primary care practices from an integrated health care delivery system in Washington state were recruited from April 1, 2021, to June 16, 2022, to participate, along with their eligible patients. Randomization occurred at the clinic level. Patients were community-dwelling adults aged 60 years or older, prescribed at least 1 medication from any of 5 targeted medication classes (opioids, sedative-hypnotics, skeletal muscle relaxants, tricyclic antidepressants, and first-generation antihistamines) for at least 3 consecutive months.Intervention: Patient education and clinician decision support. Control arm participants received usual care.Main Outcomes and Measures: The primary outcome was medically treated falls. Secondary outcomes included medication discontinuation, sustained medication discontinuation, and dose reduction of any and each target medication. Serious adverse drug withdrawal events involving opioids or sedative-hypnotics were the main safety outcome. Analyses were conducted using intent-to-treat analysis.Results: Among 2367 patient participants (mean [SD] age, 70.6 [7.6] years; 1488 women [63%]), the adjusted cumulative incidence rate of a first medically treated fall at 18 months was 0.33 (95% CI, 0.29-0.37) in the intervention group and 0.30 (95% CI, 0.27-0.34) in the usual care group (estimated adjusted hazard ratio, 1.11 (95% CI, 0.94-1.31) (P = .11). There were significant differences favoring the intervention group in discontinuation, sustained discontinuation, and dose reduction of tricyclic antidepressants at 6 months (discontinuation adjusted rate: intervention group, 0.23 [95% CI, 0.18-0.28] vs usual care group, 0.13 [95% CI, 0.09-0.17]; adjusted relative risk, 1.79 [95% CI, 1.29-2.50]; P = .001) and secondary time points (9, 12, and 15 months).Conclusions and Relevance: In this randomized clinical trial of a health system–embedded deprescribing intervention targeting community-dwelling older adults prescribed central nervous system–active medications and their primary care clinicians, the intervention was no more effective than usual care in reducing medically treated falls. For health systems that attend to deprescribing as part of routine clinical practice, additional interventions may confer modest benefits on prescribing without a measurable effect on clinical outcomes.Trial Registration: ClinicalTrials.gov Identifier: NCT05689554

1 March 2018 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
ATAnne M. Turner
Anne M. Turner
KOKatie Osterhage
Katie Osterhage
JLJulie Loughran
Julie Loughran
IPIan Painter
Ian Painter
GDGeorge Demiris
George Demiris
EPElizabeth A Phelan
Elizabeth A Phelan

17 December 2022 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
YZYuanjin Zhou
Yuanjin Zhou
CBClara Berridge
Clara Berridge
NHNancy R. Hooyman
Nancy R. Hooyman
TSTatiana Sadak
Tatiana Sadak
TMTracy M. Mroz
Tracy M. Mroz
EPElizabeth A Phelan
Elizabeth A Phelan
Background: Although older adults living with dementia (OLWD) are at high risk for falls, few strategies that effectively reduce falls among OLWD have been identified. Dementia care partners (hereinafter referred to as “care partners”) may have a critical role in fall risk management (FRM). However, little is known about the ways care partners behave that may be relevant to FRM and how to effectively engage them in FRM. Methods: Semi-structured, in-depth interviews were conducted with 14 primary care partners (age: 48–87; 79% women; 50% spouses/partners; 64% completed college; 21% people of colour) of community-dwelling OLWD to examine their FRM behaviours, and their observations of behaviours adopted by other care partners who were secondary in the caring role. Results: The analysis of interview data suggested a novel behavioural framework that consisted of eight domains of FRM behaviours adopted across four stages. The domains of FRM behaviours were 1. functional mobility assistance, 2. assessing and addressing health conditions, 3. health promotion support, 4. safety supervision, 5. modification of the physical environment, 6. receiving, seeking, and coordinating care, 7. learning, and 8. self-adjustment. Four stages of FRM included 1. supporting before dementia onset, 2. preventing falls, 3. preparing to respond to falls, and 4. responding to falls. FRM behaviours varied by the care partners’ caring responsibilities. Primary care partners engaged in behaviours from all eight behavioural domains; they often provided functional mobility assistance, safety supervision, and modification of the physical environment for managing fall risk. They also adopted behaviours of assessing and addressing health conditions, health promotion support, and receiving, seeking and coordinating care without realizing their relevance to FRM. Secondary care partners were reported to assist in health promotion support, safety supervision, modification of the physical environment, and receiving, seeking, and coordinating care. Conclusions: The multi-domain and multi-stage framework derived from this study can inform the development of tools and interventions to effectively engage care partners in managing fall risk for community-dwelling OLWD.